大葉大學圖書館 |

Resistance of cancer cells to CTL-mediated immunotherapy[electronic resource] /

紀錄類型:	書目-語言資料,印刷品 : Monograph/item
杜威分類號:	616.99406
書名/作者:	Resistance of cancer cells to CTL-mediated immunotherapy/ edited by Benjamin Bonavida, Salem Chouaib.
其他作者:	Bonavida, Benjamin.
出版者:	Cham : : Springer International Publishing :, 2015.
面頁冊數:	xiv, 353 p. : : ill. (some col.), digital ;; 24 cm.
Contained By:	Springer eBooks
標題:	Drug resistance in cancer cells.
標題:	Cancer - Immunotherapy.
標題:	Biomedicine.
標題:	Cancer Research.
標題:	Drug Resistance.
標題:	Molecular Medicine.
ISBN:	9783319178073 (electronic bk.)
ISBN:	9783319178066 (paper)
摘要、提要註:	This book, written by leading investigators, brings together the latest knowledge about key aspects of the most rapidly progressing fields of tumor escape and tumor resistance to CTL. Readers will benefit from a collection of outstanding surveys that cover some factors regulating resistance to CTL cytotoxicity, the influence of tumor microenvironment, and the resistance to death ligands, mediated apoptosis, and means to reverse resistance. This remarkable volume also emphasizes the future directions that may lead to the design of more innovative, refined, and integrative immunotherapies to target tumor plasticity and heterogeneity, and help to overcome the inherent limitations of current treatments. By providing a broad scope of innovative concepts in the burgeoning field of cancer biology and immunotherapy, this volume will be of exceptional interest and a valuable reference for scientists, clinicians, health professionals, and biopharmaceutical companies working in the field of cancer immunotherapy.
電子資源:	http://dx.doi.org/10.1007/978-3-319-17807-3

Resistance of cancer cells to CTL-mediated immunotherapy[electronic resource] /
Resistance of cancer cells to CTL-mediated immunotherapy[electronic resource] /edited by Benjamin Bonavida, Salem Chouaib. - Cham :Springer International Publishing :2015. - xiv, 353 p. :ill. (some col.), digital ;24 cm. - Resistance to targeted anti-cancer therapeutics,v.72196-5501 ;. - Resistance to targeted anti-cancer therapeutics ;v.4..

This book, written by leading investigators, brings together the latest knowledge about key aspects of the most rapidly progressing fields of tumor escape and tumor resistance to CTL. Readers will benefit from a collection of outstanding surveys that cover some factors regulating resistance to CTL cytotoxicity, the influence of tumor microenvironment, and the resistance to death ligands, mediated apoptosis, and means to reverse resistance. This remarkable volume also emphasizes the future directions that may lead to the design of more innovative, refined, and integrative immunotherapies to target tumor plasticity and heterogeneity, and help to overcome the inherent limitations of current treatments. By providing a broad scope of innovative concepts in the burgeoning field of cancer biology and immunotherapy, this volume will be of exceptional interest and a valuable reference for scientists, clinicians, health professionals, and biopharmaceutical companies working in the field of cancer immunotherapy.

ISBN: 9783319178073 (electronic bk.)

Standard No.: 10.1007/978-3-319-17807-3doiSubjects--Topical Terms:

603048
Drug resistance in cancer cells.

LC Class. No.: RC271.I45

Dewey Class. No.: 616.99406

Resistance of cancer cells to CTL-mediated immunotherapy[electronic resource] /
LDR:02063nam a2200313 a 4500 001 439157
003 DE-He213
005 20160111144550.0
006 m d
007 cr nn 008maaau
008 160322s2015 gw s 0 eng d
020 $a 9783319178073 (electronic bk.)
020 $a 9783319178066 (paper)
024 7 $a 10.1007/978-3-319-17807-3 $2 doi
035 $a 978-3-319-17807-3
040 $a GP $c GP
041 0 $a eng
050 4 $a RC271.I45
072 7 $a MJCL $2 bicssc
072 7 $a MED062000 $2 bisacsh
082 0 4 $a 616.99406 $2 23
090 $a RC271.I45 $b R433 2015
245 0 0 $a Resistance of cancer cells to CTL-mediated immunotherapy $h [electronic resource] / $c edited by Benjamin Bonavida, Salem Chouaib.
260 $a Cham : $b Springer International Publishing : $b Imprint: Springer, $c 2015.
300 $a xiv, 353 p. : $b ill. (some col.), digital ; $c 24 cm.
490 1 $a Resistance to targeted anti-cancer therapeutics, $x 2196-5501 ; $v v.7
520 $a This book, written by leading investigators, brings together the latest knowledge about key aspects of the most rapidly progressing fields of tumor escape and tumor resistance to CTL. Readers will benefit from a collection of outstanding surveys that cover some factors regulating resistance to CTL cytotoxicity, the influence of tumor microenvironment, and the resistance to death ligands, mediated apoptosis, and means to reverse resistance. This remarkable volume also emphasizes the future directions that may lead to the design of more innovative, refined, and integrative immunotherapies to target tumor plasticity and heterogeneity, and help to overcome the inherent limitations of current treatments. By providing a broad scope of innovative concepts in the burgeoning field of cancer biology and immunotherapy, this volume will be of exceptional interest and a valuable reference for scientists, clinicians, health professionals, and biopharmaceutical companies working in the field of cancer immunotherapy.
650 0 $a Drug resistance in cancer cells. $3 603048
650 0 $a Cancer $x Immunotherapy. $3 406740
650 1 4 $a Biomedicine. $3 463454
650 2 4 $a Cancer Research. $3 463530
650 2 4 $a Drug Resistance. $3 466595
650 2 4 $a Molecular Medicine. $3 463625
700 1 $a Bonavida, Benjamin. $3 626101
700 1 $a Chouaib, Salem. $3 626803
710 2 $a SpringerLink (Online service) $3 463450
773 0 $t Springer eBooks
830 0 $a Resistance to targeted anti-cancer therapeutics ; $v v.4. $3 603047
856 4 0 $u http://dx.doi.org/10.1007/978-3-319-17807-3
950 $a Biomedical and Life Sciences (Springer-11642)